Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

10.72
Delayed Data
As of Feb 27
 -0.05 / -0.46%
Today’s Change
4.13
Today|||52-Week Range
12.00
-5.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues7.8M13.0M27.8M28.0M
 
 
 
 
 
Depreciation And Amortization663.0K886.0K1.4M570.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses35.4M35.7M40.4M51.2M
 
 
 
 
 
Research And Development30.1M30.3M33.8M43.6M
 
 
 
 
 
Total Operating Expenses36.1M36.5M41.7M51.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-28.2M-23.5M-13.9M-23.7M
 
 
 
 
 
Interest Expense On Debt4.5M4.5M4.6M4.6M
 
 
 
 
 
Other Expenses330.0K236.0K161.0K265.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-32.3M-27.8M-18.3M-28.0M
 
 
 
 
 
Minority Interest-711.0K-169.0K-181.0K-137.0K
 
 
 
 
 
Net Income-33.1M-27.6M-18.1M-27.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS102.4M102.9M103.8M104.9M
 
 
 
 
 
Shares To Calculate EPS Diluted102.4M102.9M103.8M104.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.33-$0.27-$0.17-$0.27
 
 
 
 
 
EPS Diluted-$0.33-$0.27-$0.17-$0.27
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account